Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Sponsor
Luzerner Kantonsspital
Study ID
NCT07256704
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hypnosis — OTHER
    Hypnosis sessions designed to improve attentional control and reduce fatigue in patients with neurological conditions (stroke, TBI, MS). The intervention involves guided hypnotic induction and suggestions tailored to enhance cognitive focus and energy management.

Study Details

This feasibility study investigates the potential of hypnosis as a complementary therapy to improve attentional deficits and fatigue in patients with neurological diseases such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation methods. By integrating hypnosis with standard care, and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the practicality, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

Key Dates

First listed
Dec 1, 2025
Start date
Nov 18, 2025
Status verified
Nov 2025
Primary completion
Jul 31, 2029
Completion
Jul 31, 2029

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Hypnosis Intervention Participants receive hypnosis sessions designed to improve attention and reduce fatigue.
  • Sham Comparator: Control
    Sham Hypnosis Control Participants receive sham hypnosis sessions serving as a control condition.

Primary Outcome Measure

Feasibility of the study design and procedures [ Time Frame: From enrollment to the end of treatment at 3 weeks ]

Central Contacts

Find similar trials

Related Studies